Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Burosumab
Price: Check
Purity: 98.4%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

1610833-03-8

1610833-03-8 structure

1610833-03-8 structure

Name: Burosumab
Chemical Name: Burosumab
CAS Number: 1610833-03-8
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Others
Create Date: 2023-01-30 16:48:55
Modify Date: 2025-11-27 17:53:20
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].

Name	Burosumab

Description	Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
Target	FGF23[1]
References	[1]. Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children. Front Endocrinol (Lausanne). 2020 May 28;11:338. [2]. Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1.

No Any Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.